Silphium Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
Silphium Asset Management's ONCE Position: Q4 2019 in Review
Silphium Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 69,399 shares — an estimated $6.73M sold.
Silphium Asset Management first reported a position in ONCE in Q2 2019 and held it in 2 quarters. The position peaked at $6.73M in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- Silphium Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- Silphium Asset Management sold 69,399 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $6.73M.
- Silphium Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
- Silphium Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $6.73M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on Silphium Asset Management's 13F filing for Q4 2019, filed 30 Jan 2025.